Table 2.
Cardio-metabolic and renal responses of the omnivore (OMV) vs. lacto-ovo vegetarian (LOV) groups at baseline and at the end of each protein quantity-specific period
Measurement a | Group | Baseline b | 10% Protein | 20% Protein | 30% Protein |
---|---|---|---|---|---|
Fasting Lipid/Lipoprotein Status | |||||
Total cholesterol c, mg/dL | OMV | 186 ± 9 | 164 ± 5 | 151 ± 8 | 154 ± 8 |
LOV | 176 ± 6 | 149 ± 6 | 145 ± 6 | 143 ± 6 | |
HDL-C, mg/dL | OMV | 50 ± 3 | 44 ± 2 | 40 ± 3 | 42 ± 2 |
LOV | 53 ± 3 | 44 ± 2 | 44 ± 2 | 44 ± 2 | |
LDL-C, mg/dL | OMV | 112 ± 7 | 94 ± 5 | 89 ± 6 | 92 ± 5 |
LOV | 102 ± 6 | 83 ± 5 | 81 ± 4 | 82 ± 5 | |
Triacylglycerol c, mg/dL | OMV | 135 ± 12 | 124 ± 9 | 113 ± 4 | 107 ± 9 |
LOV | 107 ± 10 | 115 ± 9 | 97 ± 9 | 99 ± 9 | |
APO-A1 d, mg/dL | OMV | 145 ± 8 | 123 ± 5 | 122 ± 5 | 120 ± 4 |
LOV | 143 ± 7 | 121 ± 6 | 117 ± 4 | 118 ± 5 | |
APO-B c, mg/dL | OMV | 91 ± 5 | 84 ± 4 | 81 ± 4 | 78 ± 3 |
LOV | 83 ± 4 | 77 ± 4 | 71 ± 3 | 70 ± 3 | |
Glycemic Status | |||||
Fasting glucose, mg/dL | OMV | 86 ± 3 | 91 ± 2 | 90 ± 2 | 89 ± 2 |
LOV | 89 ± 2 | 92 ± 2 | 90 ± 1 | 91 ± 2 | |
Fasting insulin, µU/mL | OMV | 11.6 ± 1.6 | 8.3 ± 1.2 | 7.6 ± 0.8 | 10.1 ± 2.4 |
LOV | 9.7 ± 1.3 | 6.9 ± 0.8 | 6.2 ± 0.9 | 6.2 ± 0.7 | |
HOMA-IR | OMV | 2.54 ± 0.42 | 1.90 ± 0.29 | 1.73 ± 0.19 | 2.38 ± 0.68 |
LOV | 2.14 ± 0.29 | 1.59 ± 0.19 | 1.36 ± 0.20 | 1.42 ± 0.18 | |
HOMA-β, % | OMV | 144.9 ± 30.8 | 104.9 ± 11.9 | 98.9 ± 7.3 | 124.9 ± 25.2 |
LOV | 150.4 ± 25.0 | 87.5 ± 9.3 | 87.5 ± 13.3 | 88.8 ± 8.6 | |
Glucose AUC e, mg/dL × 240 min | OMV | 1557 ± 282 | 1559 ± 278 | 2164 ± 288 | |
LOV | 2182 ± 274 | 2156 ± 270 | 2245 ± 279 | ||
Insulin AUC ef, µU/mL × 240 min | OMV | 3964 ± 451 | 3367 ± 411 | 4565 ± 639 | |
LOV | 4133 ± 365 | 3891 ± 443 | 4675 ± 637 | ||
Blood Pressure Status g | |||||
Reclining systolic BP, mm Hg | OMV | 122 ± 2 | 116 ± 3 | 116 ± 3 | 112 ± 2 |
LOV | 123 ± 3 | 117 ± 3 | 118 ± 4 | 115 ± 3 | |
Reclining Diastolic BP, mm Hg | OMV | 81 ± 2 | 77 ± 2 | 76 ± 2 | 73 ± 1 |
LOV | 78 ± 2 | 75 ± 1 | 76 ± 2 | 75 ± 2 | |
Sitting Systolic BP, mm Hg | OMV | 116 ± 3 | 111 ± 3 | 112 ± 2 | 108 ± 2 |
LOV | 120 ± 4 | 115 ± 3 | 112 ± 4 | 110 ± 3 | |
Sitting Diastolic BP, mm Hg | OMV | 74 ± 2 | 70 ± 2 | 69 ± 2 | 67 ± 1 |
LOV | 74 ± 2 | 71 ± 2 | 70 ± 2 | 69 ± 2 | |
Fasting Renal Status g | |||||
Serum Creatinine, mg/dL | OMV | 0.90 ± 0.05 | 0.86 ± 0.04 | 0.90 ± 0.04 | 0.86 ± 0.05 |
LOV | 0.92 ± 0.04 | 0.83 ± 0.04 | 0.82 ± 0.03 | 0.82 ± 0.03 | |
Creatinine clearance rate, mL/min | OMV | 111 ± 6 | 108 ± 7 | 103 ± 6 | 110 ± 8 |
LOV | 104 ± 6 | 107 ± 7 | 107 ± 6 | 106 ± 6 | |
Glomerular filtration rate, mL/min | OMV | 83 ± 4 | 86 ± 4 | 83 ± 4 | 85 ± 4 |
LOV | 80 ± 4 | 88 ± 4 | 88 ± 4 | 87 ± 4 | |
Resting Energy Expenditure | |||||
REEf, kcal/kg/h h | OMV | 0.89 ± 0.04 | 0.90 ± 0.04 | 0.90 ± 0.04 | 0.87 ± 0.04 |
LOV | 0.92 ± 0.03 | 0.86 ± 0.05 | 0.90 ± 0.04 | 0.98 ± 0.04 | |
REEpp AUC e, kcal/kg/h × 4 h | OMV | 0.47 ± 0.09 | 0.40 ± 0.06 | 0.58 ± 0.11 | |
LOV | 0.66 ± 0.01 | 0.58 ± 0.12 | 0.48 ± 0.10 | ||
Thermic effect of feeding i (%) | OMV | 8.9 ± 1.6 | 7.7 ± 1.3 | 11.0 ± 2.1 | |
LOV | 12.7 ± 2.0 | 11.1 ± 2.4 | 9.1 ± 1.8 |
a Data are Means ± SEMs; b No differences at baseline between groups; c There was a main effect of protein quantity (p < 0.05). Post-hoc: 10% > 20% and 30% protein (p < 0.05); d LOV M = 6, F = 10 for 30% protein; e Area under the curve was calculated to represent the postprandial response to consuming the acute test breakfast; f There was a main effect of protein quantity (p < 0.05). Post-hoc: 20% < 30% (p < 0.05); g LOV M = 5, F = 11 for 30% protein; h There was a protein source-by-quantity interaction (p < 0.05). No main effects of protein source or quantity. Post-hoc: LOV 30% > OMV 30% protein, (p < 0.05); i The thermic effect of feeding was expressed as: REEpp AUC (kcal) divided by the calorie of the test breakfast.